Medartis Revises 2022 Outlook Based on Headwinds

Medartis reported 1H22 orthopedic sales of $92.8 million, +17.2% compared to the first half of 2021.

Medartis' extensive wrist portfolio and hand products from recently acquired KeriMedical drove share gains in the EMEA region. However, COVID lockdowns severely impacted the company's largest APAC markets of Australia and New Zealand....

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us